FDA shows unease about marketing approval applications based on single-country trials
In 2019, the director of the US FDA’s Oncology Center of Excellence, Richard Pazdur, suggested that the approval pathway for…
In 2019, the director of the US FDA’s Oncology Center of Excellence, Richard Pazdur, suggested that the approval pathway for…
Credit: JLMcAnally As is customary, as January begins, so do price increases in the United States. Several reports tracking January…
The US Institute for Clinical and Economic Review (ICER) began publishing health technology assessments (HTAs) for innovative medicines in 2014…